Skip to main content
NCBI home page
CNS Drug Reviews logoLink to CNS Drug Reviews
letter
. 2006 Jun 7;10(1):83–85. doi: 10.1111/j.1527-3458.2004.tb00005.x

Moclobemide and the Risk of Serotonin Toxicity (or Serotonin Syndrome)

Comment to the manuscript by Udo Bonnet, Moclobemide: Therapeutic Use and Clinical Studies. CNS Drug Reviews 2003;9:97–140.

Ken Gillman 1
PMCID: PMC6494166  PMID: 15046013

Full Text

The Full Text of this article is available as a PDF (47.0 KB).

REFERENCES

  • 1. Bonnet U. Moclobemide: Therapeutic use and clinical studies. CNS Drug Rev 2003;9:97–140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Chan BS, Graudins A, Whyte IM, Dawson AH, Braitberg G, Duggan GG. Serotonin syndrome resulting from drug interactions. Med J Aust 1998;169:523–525. [DOI] [PubMed] [Google Scholar]
  • 3. Dingenmanse J, Wallnofer A, Gieschke R, Guentert T, Amrein R. Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the “serotonin syndrome.” Clin Pharmacol Ther 1998;63:403–413. [DOI] [PubMed] [Google Scholar]
  • 4. Dunkley E, Isbister G, Sibbritt D, Dawson A, Whyte IM. Hunter Serotonin Toxicity Criteria: a simple and accurate diagnostic decision rule for serotonin toxicity. Quart J Med 2003;96:635–642. [DOI] [PubMed] [Google Scholar]
  • 5. Ferrer‐Dufol A, Peres‐Aradros C, Murillo EC, Marques‐Alamo JM. Fatal serotonin syndrome caused by moclobemide‐clomipramine overdose. J Toxicol Clin Toxicol 1998;36:31–32. [DOI] [PubMed] [Google Scholar]
  • 6. Gaillard Y and Pepin G. Moclobemide fatalities: Report of two cases and analytical determinations by GC‐MS and HPLC‐PDA after solid‐phase extraction. Forensic Sci Int 1997;87:239–248. [DOI] [PubMed] [Google Scholar]
  • 7. Gillman PK, Serotonin toxicity (serotonin syndrome): A current analysis. 2003, Available at: http://www.psychotropical.com/SerotoninToxicity.doc: Psychopharmacology Update Notes [Online].
  • 8. Gillman PK. Serotonin syndrome: History and risk. Fund Clin Pharmacol 1998;12:482–491. [DOI] [PubMed] [Google Scholar]
  • 9. Gillman PK. Serotonin syndrome: Clomipramine too soon after moclobemide. Int Clin Psychopharmacol 1997;12:339–342. [DOI] [PubMed] [Google Scholar]
  • 10. Gillman PK. Comments on “Serotonin syndrome during treatment with paroxetine and risperidone.” J Clin Psychopharmacol 2001;21:344–345. [DOI] [PubMed] [Google Scholar]
  • 11. Gillman PK. Serotonin syndrome treated with chlorpromazine. J Clin Psychopharmacol 1997;17:128–129. [DOI] [PubMed] [Google Scholar]
  • 12. Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol (Oxf) 1999;13:100–109. [DOI] [PubMed] [Google Scholar]
  • 13. Graudins A, Stearman A, Chan B. Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med 1998;16:615–619. [DOI] [PubMed] [Google Scholar]
  • 14. Hawley CJ, Quick SJ, Ratnam S, Pattinson HA, McPhee S. Safety and tolerability of combined treatment with moclobemide and SSRIs – a systematic study of 50 patients. Int Clin Psychopharmacol 1996;11:187–191. [DOI] [PubMed] [Google Scholar]
  • 15. Hetzel W. Safety of moclobemide taken in overdose for attempted suicide. Psychopharmacology (Berl) 1992;106:S127–S129. [DOI] [PubMed] [Google Scholar]
  • 16. Isbister G, Hackett L, Dawson A, Whyte I, Smith ABr Moclobemide poisoning: Toxicokinetics and occurrence of serotonin toxicity. J Clin Pharmacol 2003;56:441–450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Kuisma MJ. Fatal serotonin syndrome with trismus. Ann Emerg Med 1995;26:108. [DOI] [PubMed] [Google Scholar]
  • 18. Liebenberg R, Berk M, Winkler G. Serotonergic syndrome after concomitant use of moclobemide and fluoxetine. Hum Psychopharmacol 1996;11:146–147. [Google Scholar]
  • 19. McIntyre IM, King CV, Staikos V, Gall J, Drummer OH. A fatality involving moclobemide, sertraline, and pimozide. J Forensic Sci 1997;42:951–953. [PubMed] [Google Scholar]
  • 20. Radomski JW, Dursun AM, Reveley MA, Kutcher SP. An exploratory approach to the serotonin syndrome: An update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses 2000;55:218–224. [DOI] [PubMed] [Google Scholar]
  • 21. Rodge S, Hilberg T, Teige B. Fatal combined intoxication with new antidepressants. Human cases and an experimental study of postmortem moclobemide redistribution. Forensic Sci Int 1999;100:109–116. [DOI] [PubMed] [Google Scholar]
  • 22. Singer PP, Jones GR. An uncommon fatality due to moclobemide and paroxetine. J Anal Toxicol 1997;21(6):518–520. [DOI] [PubMed] [Google Scholar]
  • 23. Whyte IM, Buckley NA, Dawson AH. Data collection in clinical toxicology: Are there too many variables J Toxicol Clin Toxicol 2002;40:223–230. [DOI] [PubMed] [Google Scholar]
  • 24. Whyte IM, Dawson AH, Buckley NA. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. Quart J Med 2003;96:369–374. [DOI] [PubMed] [Google Scholar]

Articles from CNS Drug Reviews are provided here courtesy of Wiley

RESOURCES